Clinical Trial Update: Gemcitabine Plus Rapamycin Versus Gemcitabine to Treat Advanced Soft Tissue Sarcoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial comparing gemcitabine with versus without rapamycin for advanced soft tissue sarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Rapamycin (sirolimus)

Snippet

Sponsor: Grupo Espanol de Investigacion en Sarcomas | Conditions: Advanced Soft Tissue Sarcoma | Phase 1, Phase 2 | Status: COMPLETED